Our INNOSURFACE® Platform Technology is an advanced modular system that enables the structural integration of diverse therapeutic agents—including small molecules, proteins, and nanozymes (CORE)—with a broad range of biocompatible and deliverable surface materials such as polymers, liposomes, lipids, and silica (ENCAPSULATION). This flexible architecture allows for in-situ surface engineering and encapsulation, facilitating tailored nanomedicine formulation based on specific therapeutic needs.

Exclusively developed by OmniParticles, INNOSURFACE® revolutionizes nanomedicine by enabling precise assembly and modification at the interface of drug and delivery system. From laboratory-scale to commercial manufacturing, the platform ensures consistent quality and scalability, effectively addressing the challenge of maintaining nanoparticle uniformity.

Fully compliant with GMP standards, INNOSURFACE® supports regulatory readiness while offering a highly customizable framework—from therapeutic payload integration to surface chemistry tuning—meeting diverse clinical and formulation requirements with exceptional precision.